24 KiB
title, docid, authors, breadcrumbs, category, cmeTopicId, documentVersionId, imageCount, lastUpdated, pageDescription, pageKeywords, pageTitle, enhancedTitle, type, references, breadcrumbs
| title | docid | authors | breadcrumbs | category | cmeTopicId | documentVersionId | imageCount | lastUpdated | pageDescription | pageKeywords | pageTitle | enhancedTitle | type | references | breadcrumbs | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cerebral Hyperperfusion Syndrome | e66febb9-d79e-4f04-88b1-205ba8a0822f |
|
|
Brain | 32753552-21d2-4b3a-bb83-721ad78e8c95 | 26eadfe0-1ff5-4d74-8dfb-927c31c6e893 | 15 | 08/05/20 | Cerebral Hyperperfusion Syndrome | Brain, Diagnosis, Pathology-Based Diagnoses, Stroke, Cerebral Ischemia and Infarction, Cerebral Hyperperfusion Syndrome | Cerebral Hyperperfusion Syndrome | STATdx | Cerebral Hyperperfusion Syndrome | DX | true |
|
title: "Cerebral Hyperperfusion Syndrome" docid: "e66febb9-d79e-4f04-88b1-205ba8a0822f" authors:
- key: "5cff4116-3654-4b3a-bb75-5ebe0b8c9850" value: "Anne G. Osborn, MD, FACR" breadcrumbs:
- name: "Brain" slug: "brain" treeNodeId: "6d8829f1-14d7-45af-8675-255189aa526a"
- name: "Diagnosis" slug: "diagnosis" treeNodeId: "51c00394-446e-4a38-94af-d3b1d14d34e8"
- name: "Pathology-Based Diagnoses" slug: "pathology-based-diagnoses" treeNodeId: "d9d3a8ed-f21b-4831-8c77-591a3500ef77"
- name: "Stroke" slug: "stroke" treeNodeId: "12307683-f1ff-4823-a7d3-b10b40f9fd82"
- name: "Cerebral Ischemia and Infarction" slug: "cerebral-ischemia-and-infarction" treeNodeId: "51051846-a223-42f7-b626-2a5a26cf6c44"
- name: "Cerebral Hyperperfusion Syndrome" slug: "cerebral-hyperperfusion-syndrome" treeNodeId: null category: "Brain" cmeTopicId: "32753552-21d2-4b3a-bb83-721ad78e8c95" documentVersionId: "26eadfe0-1ff5-4d74-8dfb-927c31c6e893" imageCount: 15 lastUpdated: "08/05/20" pageDescription: "Cerebral Hyperperfusion Syndrome" pageKeywords: "Brain, Diagnosis, Pathology-Based Diagnoses, Stroke, Cerebral Ischemia and Infarction, Cerebral Hyperperfusion Syndrome" pageTitle: "Cerebral Hyperperfusion Syndrome | STATdx" enhancedTitle: "Cerebral Hyperperfusion Syndrome" type: "DX" references: true breadcrumbs:
- "Brain"
- "Diagnosis"
- "Pathology-Based Diagnoses"
- "Stroke"
- "Cerebral Ischemia and Infarction"
- "Cerebral Hyperperfusion Syndrome"
KEY FACTS
-
Terminology
- Rare disorder most commonly occurring as complication of cerebral revascularization - Other etiologies less common - Status epilepticus - MELAS
- Major increase in ipsilateral cerebral blood flow (CBF) well above normal metabolic demands
-
Imaging
- Ipsilateral gyral swelling, sulcal effacement in post carotid endarterectomy (CEA) patient
- ↑ CBF, cerebral blood volume (CBV) on perfusion MR (pMR), perfusion CT (pCT)
- Early draining vein, capillary blush on DSA after revascularization
-
Top Differential Diagnoses
- Acute cerebral ischemia-infarction
- Status epilepticus
- MELAS
- Acute hypertensive encephalopathy, PRES
- Hypercapnia
-
Pathology
- Cerebral hyperperfusion syndrome (CHS) probably caused by maladaptive autoregulatory mechanisms, altered cerebral hemodynamics - "Normal perfusion pressure breakthrough" - Rapid restoration of normal perfusion following revascularization → hyperperfusion in previously underperfused brain
-
Clinical Issues
- ~ 3% of post-CEA patients develop CHS
- Triad of unilateral headache, neurologic deficit, seizures - Variable cognitive impairment - Ipsilateral face, eye pain
-
Diagnostic Checklist
- Need to distinguish stroke/TIA from CHS
TERMINOLOGY
-
Abbreviations
- Cerebral hyperperfusion syndrome (CHS)
-
Synonyms
- Post-CEA hyperperfusion
- Luxury perfusion
-
Definitions
- Rare (3.5%) disorder most commonly occurring as complication of cerebral revascularization - Mildly ↑ cerebral blood flow (CBF) common after carotid endarterectomy (CEA), typically asymptomatic - CHS defined as ≥ 100% increase in rCBF compared to preoperative values
- Major increase in ipsilateral CBF well above normal metabolic demands - Usually following carotid revascularization procedure - Carotid endarterectomy - Angioplasty with stenting - Thrombolysis - May occur in other settings [e.g., status epilepticus, mitochondrial encephalopathy lactic acidosis and stroke-like episodes (MELAS)] - After drainage of chronic subdural hematomas
IMAGING
-
General Features
-
Best diagnostic clue
- Ipsilateral gyral swelling, sulcal effacement in post-CEA patient - ↑ CBF, cerebral blood volume (CBV) on perfusion MR (pMR), perfusion CT (pCT) -
Size
- Variable -
Morphology
- Follows vascular distribution
-
-
Angiographic Findings
- Sentinel signs suggestive of maximal arteriolar dilation, disrupted cerebral autoregulation - Early draining vein in treated ischemic territory - Early contrast filling vein(s) in late arterial or capillary phase - Prominent capillary blush (luxury perfusion) denser than rest of arterial territory - Persists late into venous phase
-
Imaging Recommendations
-
Best imaging tool
- MR with DWI, PWI - SPECT -
Protocol advice
- Add T2* (GRE or SWI) to look for hemorrhage
-
-
CT Findings
-
NECT
- Gyral swelling - Cortical effacement - Patchy or diffuse white matter (WM) edema - Posterior parietooccipital lobe most common - ± hypodensity (may occur without attenuation alterations) - Frank hemorrhage in < 1% -
CECT
- Prominent vessels with ↑ intravascular enhancement - May demonstrate contrast extravasation in severe cases (rare) -
CT perfusion - Elevated CBF, ↓ TTP
-
-
MR Findings
-
T1WI
- Cortical swelling - ± mild hypointensity - Sulci effaced -
T2WI
- Gyral swelling, hyperintensity -
FLAIR
- Hyperintense cortex - Hyperintensity in subarachnoid spaces on postcontrast FLAIR reported 2° to blood-brain barrier (BBB) disruption -
T2* GRE
- Frank hemorrhage in < 1% - Blooming on GRE or SWI -
DWI
- Usually normal, as edema is vasogenic, not cytotoxic - ~ 25% show small foci of restricted diffusion compared to preoperative DWI -
PWI
- Elevated CBV, CBF - Prolonged MTT - Side-to-side difference of 3 seconds predictive of CHS -
T1WI C+
- May be normal - May show slightly increased prominence of cerebral vessels - Parenchymal enhancement in severe cases -
MRA
- Preoperative ↓ signal intensity in middle cerebral artery (MCA) may identify patients at risk for CHS
-
-
Other Modality Findings
- SPECT - N-isopropyl-p-I-123-iodoamphetamine or I-123-iomazenil SPECT - Shows hyperperfusion in ipsilateral cerebral hemisphere after surgery - CBF ≥ 100% in revascularized territory from baseline - Can be detected even in asymptomatic patients - May be correlated with long-term neuronal damage that CT, MR do not detect - May be associated with crossed cerebellar diaschisis
-
Ultrasonographic Findings
- Transcranial color duplex (TCD) - 1.5-2x increase in MCA flow velocity
DIFFERENTIAL DIAGNOSIS
-
Acute Cerebral Ischemia-Infarction
- TTP/MTT prolonged (not decreased)
- Typically shows restriction on DWI (CHS often negative)
-
- Metabolic hyperperfusion in affected brain
- History of seizure helpful but may not be available
-
Acute Hypertensive Encephalopathy, PRES
- Failed autoregulation → hyperperfusion → endothelial injury/vasogenic edema
- Predilection for posterior circulation
- Markedly elevated blood pressure (many etiologies) - Eclampsia, preeclampsia - Chemotherapy - Renal failure - Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura - Drug abuse (especially cocaine)
-
MELAS
- Acute oxidative phosphorylation defect
- Stroke-like episodes related to vasogenic edema, hyperperfusion, neuronal damage
- Cortical hyperintensity, enhancement
- Perform MRS in unaffected region, look for lactate
-
Hypercapnia
- Carbon dioxide is potent stimulator of CBF
- Vasodilatory effect on cerebral vasculature
PATHOLOGY
-
General Features
-
Etiology
- Theories - Impaired cerebral autoregulation - Damage from free radicals - Baroreceptor reflex breakdown - Trigeminovascular reflex (vasoactive neuropeptide release) - CHS probably caused by maladaptive autoregulatory mechanisms, altered cerebral hemodynamics - "Normal perfusion pressure breakthrough" - Chronic ischemia → impaired autoregulation - Loss of normal vasoconstriction - "Resistance" vessels become chronically dilated - Rapid restoration of normal perfusion following revascularization → hyperperfusion in previously underperfused brain - Cognitive impairment after CEA or angioplasty/stenting may result from - Cerebral embolization during dissection, stenting - Global cerebral hypoperfusion during carotid cross-clamping - Cerebral hyperperfusion syndrome
-
CLINICAL ISSUES
-
Presentation
-
Most common signs/symptoms
- Symptoms range from mild to severe/life-threatening - Ipsilateral headache, neurologic deficit and seizures -
Other signs/symptoms - Variable cognitive impairment - Face, eye pain
-
Timing - Peaks at 12 h after carotid angioplasty/stenting (CAS) - 6 days after CEA - Can be delayed by up to 1 month
-
-
Demographics
-
Age
- For postendarterectomy CHS, generally older patients - For other etiologies (e.g., seizure, MELAS), any age -
Epidemiology
- ~ 3-4% of post-CEA patients develop mild CHS - Highest risk = impaired cerebrovascular reserve, asymptomatic stenosis - > 100% increase in CBF after treatment - Contralateral stenosis, chronic hypertension do not influence risk of CHS after CEA - Covariate clinical risk factors - Age - Hypertension (especially postoperative) - Diabetes - Bilateral lesions - Extent of ICA stenosis - High grade > low grade - Presence of contralateral carotid occlusion or high-grade stenosis - Duration of cross-clamping - Diminished carotid reserve - Poor collateral blood flow - Decreased cerebrovascular reactivity to acetazolamide challenge
-
-
Natural History & Prognosis
- Neurologic emergency - If not treated promptly/adequately, can cause death or severe disability
- If no intracranial hemorrhage - Usually reversible - No major tissue destruction - May result in persistent mild cognitive impairment
- 1% of CHS with intracranial hemorrhage - Poor prognosis
-
Treatment
- Prevention - Minimize intraoperative cerebral ischemia - Consider continuing postoperative anesthesia/continuous sedation - Strict postoperative blood pressure control - Staged angioplasty in at-risk patients can ↓ - Efficacious for patients with severe impairment of hemodynamic reserve in I-123 IMP SPECT
DIAGNOSTIC CHECKLIST
-
Consider
- Post-CEA/carotid artery stenting patient with neurologic deficit - Need to distinguish stroke/transient ischemic attack from CHS
8b8b5253-2a1e-4d24-9d1b-dc85e0dde35e
References
Selected References
- Lin YH et al: Update on cerebral hyperperfusion syndrome. J Neurointerv Surg. ePub, 2020
- Murai S et al: Safety and efficacy of staged angioplasty for patients at risk of hyperperfusion syndrome: a single-center retrospective study. Neuroradiology. 62(4):503-10, 2020
- Pavlov O: Rapid evacuation of chronic subdural hematoma - A possible traumatic brain injury (TBI). Med Hypotheses. 137:109539, 2020
- Sakata H et al: Symptomatic cerebral hyperperfusion after cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage. World Neurosurg. 137:379-83, 2020
- Fassaert LMM et al: Transcranial Doppler 24 hours after carotid endarterectomy accurately identifies patients not at risk of cerebral hyperperfusion syndrome. Eur J Vasc Endovasc Surg. 58(3):320-7, 2019
- Ghuman M et al: Sentinel angiographic signs of cerebral hyperperfusion after angioplasty and stenting of intracranial atherosclerotic stenosis: A technical note. AJNR Am J Neuroradiol. 40(9):1523-5, 2019
- Lin T et al: ASL perfusion features and type of circle of Willis as imaging markers for cerebral hyperperfusion after carotid revascularization: a preliminary study. Eur Radiol. 29(5):2651-8, 2019
- Omura T et al: Cerebral hyperperfusion syndrome after a burr hole drainage surgery for chronic subdural hematoma. World Neurosurg. ePub, 2019
- Sharma P et al: Cerebral hyperperfusion syndrome after chronic subdural hematoma drainage. World Neurosurg. 126:694, 2019
- Huibers AE et al: Editor's choice - Cerebral hyperperfusion syndrome after carotid artery stenting: A systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 56(3):322-33, 2018
- Kirchoff-Torres KF et al: Cerebral hyperperfusion syndrome after carotid revascularization and acute ischemic stroke. Curr Pain Headache Rep. 22(4):24, 2018
- Galyfos G et al: Cerebral hyperperfusion syndrome and intracranial hemorrhage after carotid endarterectomy or carotid stenting: A meta-analysis. J Neurol Sci. 381:74-82, 2017
- Cano EJ et al: Asymmetric brain edema after cardiac transplantation: cerebroautoregulatory failure and relative hyperperfusion. Transplant Proc. 47(1):194-7, 2015
- Horie N et al: De novo ivy sign indicates postoperative hyperperfusion in moyamoya disease. Stroke. 45(5):1488-91, 2014
Images
Selected Images
A 56-year-old man with > 70% stenosis of his proximal left cervical internal carotid artery (ICA) underwent carotid endarterectomy. A few hours after surgery, he became acutely confused and developed right-sided weakness. Perfusion source image shows markedly increased vasculature in the left hemisphere
.
A 56-year-old man with > 70% stenosis of his proximal left cervical internal carotid artery (ICA) underwent carotid endarterectomy. A few hours after surgery, he became acutely confused and developed right-sided weakness. Perfusion source image shows markedly increased vasculature in the left hemisphere
.
CT perfusion obtained in the same patient appears relatively normal, but cerebral blood flow (CBF) on the left (2a, 2b ROIs) is increased compared to the right side.
TTP in the same patient is even more striking. The abnormal side is not the right middle cerebral artery (MCA) distribution (green) but is the left side (blue) where the TTP is markedly shortened.
Axial T2 MR in the same patient shows gyral swelling, sulcal effacement, and hyperintensity in the left temporal and parietooccipital cortex/subcortical white matter
, basal ganglia
. DWI (not shown) was normal. This is a classic example of postcarotid endarterectomy hyperperfusion syndrome.
Anteroposterior view of DSA shows abrupt occlusion of the left MCA just distal to its origin
in a patient with a sudden onset of right-sided weakness and stroke-like symptoms. Little collateral filling of the distal MCA is seen.
After superselective catheterization of the left MCA and infusion of tissue plasminogen activator for 2 hours, normal circulation was restored, as shown on this AP DSA.
Following restoration of normal blood flow in the previously occluded left MCA, the patient experienced worsening right-sided weakness and throbbing headache. Axial MR perfusion study shows elevated (red area
), not decreased, CBF in the left temporal and parietal lobes.
Axial MR perfusion in the same patient shows elevated cerebral blood volume
.
Axial T1 C+ FS MR shows cerebral hyperperfusion in status epilepticus in a 52-year-old woman with left-sided weakness following prolonged seizure. Note the increased intravascular, sulcal enhancement in the right temporal lobe compared to the left hemisphere
.
pMR in the same patient shows increased CBF in the right temporal lobe
, corresponding to the increased intravascular enhancement noted on previous image.
Additional Images
Axial NECT in a patient with confusion, right-sided weakness following left CEA shows subtle increased hypodensity
in the cortex and subcortical WM of the left parieto-occipital lobes.
Axial FLAIR MR in the same patient shows hyperintensity in the cortex
and basal ganglia
.
Axial DWI MR in the same patient shows no evidence of restricted diffusion.
Axial T1 C+ FS MR in the same patient shows increased vascularity
in the left parieto-occipital region.
Coronal T1 C+ FS MR in the same patient shows a faint capillary blush
in the same area. This was cerebral hyperperfusion syndrome.